Non-Hodgkin Lymphoma

CURE’s non-Hodgkin lymphoma (NHL) page is an extensive resource of cancer information featuring the latest NHL news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on non-Hodgkin lymphoma.

Latest News

Bexobrutideg Receives Orphan Drug Designation in Waldenström Macroglobulinemia

By Ryan Scott

March 17th 2025

Bexobrutideg, a bioavailable agent, was granted orphan drug designation by the FDA for Waldenström macroglobulinemia, a type of non-Hodgkin's lymphoma.

Breyanzi Improves Responses in R/R Indolent B-Cell Non-Hodgkin Lymphoma

By Spencer Feldman

February 13th 2025

Image of Randy Moss Photo credit: Jonathan Bachman - Getty Images

Randy Moss Shares Cancer Update, “Squid Game” Star Dies and More

By Alex Biese

February 7th 2025

Coming to Terms With Hair Loss After Chemotherapy

By Amy Brewster

January 7th 2025

Expert Explains Lymphoma After Dave Coulier's Diagnosis

By Alex Biese

December 4th 2024

More News

chemoWave Propels Patients to Take Back Control in Cancer Treatment

Kristie L. Kahl

May 8th 2018

The chemoWave app, launched in July 2017, is designed to manage cancer symptoms and conditions by keeping track of a patient’s overall well-being.

Study Demonstrates Potential for New CLL Combination

Silas Inman

March 9th 2017

A recent phase 3 study showed that Imbruvica plus ublituximab may be a promising option for some patients with CLL.

The Potential of Gazyva in Advanced Indolent Non-Hodgkin Lymphoma

Laura Panjwani

June 29th 2015

CURE spoke with Bruce D. Cheson to gain a deeper understanding of adding the targeted therapy Gazyva to the chemotherapy Treanda for patients with Rituxan-refractory indolent non-Hodgkin lymphoma.